8-K
Current Report
Nautilus Biotechnology, Inc. Filed Acc 0001628280-21-011835
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading aryaiii-8xk6821.htm…